Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Neurology

Safety and Daily Living with HDL2

At a Glance

People living with Huntington disease-like 2 can improve daily safety by getting individualized help for swallowing, mobility, nutrition, and medicines, keeping an emergency plan, and using respite or palliative care to support the whole family.

Living with Huntington disease-like 2 (HDL2) requires a proactive approach to safety and a supportive environment for both you and your family. Because HDL2 is a progressive condition that mirrors Huntington’s Disease (HD), you can use the well-established safety strategies from the HD community to manage daily risks [1][2].

Recognizing “Red Flags” and Emergencies

While many changes in HDL2 happen slowly, some situations require urgent medical evaluation or explicit emergency actions. Do not wait for a scheduled appointment if you notice the following:

  • Choking or Respiratory Crisis: If there is an inability to breathe, prolonged or severe choking, or blue lips, call local emergency services immediately. For new or worsening coughing during meals without an immediate airway emergency, a “wet” or gurgly voice after drinking, or an unexplained fever (which could signal aspiration pneumonia), contact an urgent clinician line or go to an emergency department [3][4].
  • Psychiatric Crisis: If there is a suicide plan, imminent intent, severe aggression, or a severe “break” from reality (psychosis) causing immediate danger, call local emergency services immediately. Caregivers should stay with a person at immediate suicide risk while obtaining help [5][6].
  • Falls and Seizures: Falls that result in head injury or significant pain, or the sudden onset of seizures (which are rare in adults but have been reported), require immediate local emergency services [7][8].
  • Sudden Confusion: A rapid change in mental state (delirium) that is not typical for your usual cognitive progression requires urgent medical evaluation to rule out infections or medication toxicity [9].

Swallowing and Nutritional Safety

Difficulty swallowing (dysphagia) is one of the most serious complications of HDL2 because it can lead to aspiration (food or liquid entering the lungs) [10][4].

  • Surveillance: Work with a dietitian to establish an individualized weight monitoring plan. Unintended weight loss is common and can make other symptoms worse, but monitoring should not become a burden [11][12].
  • Safe Eating Habits: Work with a speech-language pathologist (SLP) to determine if you need thickened liquids or softened foods [13][10]. Do not alter textures on your own.
  • Active Focus: Try to eat in a quiet environment without distractions like TV. Focus entirely on the act of swallowing to reduce the risk of “tachyphagia” (eating too fast) [10][14].
  • Silent Aspiration: Be aware that aspiration can be “silent,” meaning you may breathe food into your lungs without coughing. Instrumental tests like a FEES (Fiberoptic Endoscopic Evaluation of Swallowing) or a videofluoroscopy may be selected and repeated based on your symptoms and the speech-language pathologist’s judgment [3][15].

Mobility and Fall Prevention

As the disease shifts from “extra” movements (chorea) to stiffness (rigidity) and slowness (bradykinesia), your risk of falling changes [16][17].

  • Environmental Adjustments: Remove throw rugs, ensure hallways are well-lit, and install grab bars in the bathroom [18].
  • Equipment: A physical therapist must assess your gait and select, fit, and train you in an appropriate assistive device. Do not buy or switch to an aid without that assessment, as inappropriate devices can worsen falls [18].
  • Medication Review: Some medications used to treat chorea or mood can cause dizziness or sedation, increasing fall risk. Always discuss a sudden change in balance with your doctor [19][9].

Support for the Whole Family

The emotional and physical toll on caregivers is significant. Research shows that caregiver burden in HD-like conditions is often driven more by behavioral symptoms—like apathy, irritability, or a lack of insight (anosognosia)—than by the movement symptoms themselves [20][21].

  • Acknowledge the Burden: Caregivers often experience a loss of social contact and physical exhaustion. It is vital to seek “respite care” (short-term relief) to prevent burnout [22][23].
  • Finding Community: Since HDL2-specific support groups are rare, you are encouraged to connect with Huntington’s disease organizations (like HDSA) or international rare-disease networks. While HDL2 has disease-specific differences, the shared daily challenges and emotional experiences mean these communities offer invaluable resources for advocacy and connection [2][22].
  • Palliative Care: Do not wait until the end of life to involve a palliative care team. They specialize in symptom relief and family support at any stage of a serious illness [24].

Common questions in this guide

When does a swallowing problem in HDL2 require emergency help?
Call local emergency services immediately if the person cannot breathe, has severe or prolonged choking, or has blue lips. New or worsening coughing during meals, a wet or gurgly voice after drinking, or an unexplained fever can signal food or liquid entering the lungs and needs urgent medical advice or emergency evaluation. These signs should not wait for a routine appointment.
How can someone with HDL2 eat more safely?
A speech-language pathologist should assess swallowing and advise whether thickened liquids or softer foods are appropriate; do not change food or drink textures without guidance. Eat in a quiet setting without television or other distractions and focus on swallowing. If food or liquid may be entering the lungs without coughing, a clinician may recommend a camera-based swallowing test called FEES or a videofluoroscopy.
What can reduce fall risk in HDL2 at home?
Remove throw rugs, improve hallway lighting, and add grab bars in the bathroom. A physical therapist should assess walking, select and fit any assistive device, and teach the person how to use it; buying one without an assessment may worsen falls. Ask the healthcare team to review medicines if balance suddenly changes or dizziness or sleepiness appears.
When is a mental health crisis with HDL2 an emergency?
Call local emergency services immediately for a suicide plan or imminent intent, severe aggression, or a severe break from reality that creates immediate danger. If someone is at immediate risk of suicide, a caregiver should stay with the person while help is obtained, when it is safe to do so. Ask the healthcare team in advance for an after-hours crisis plan and contact numbers.
Why does sudden confusion in a person with HDL2 need urgent evaluation?
A rapid change in mental state that is not typical of the person’s usual HDL2 progression needs urgent medical evaluation. Clinicians may look for treatable causes such as an infection or a medication problem. Do not assume sudden confusion is simply part of HDL2.
How can families support caregivers of someone with HDL2?
Caregiver exhaustion and loss of social contact are common, especially when apathy, irritability, or lack of insight create extra demands. Respite care can provide short-term relief and help prevent burnout. Huntington disease organizations and rare-disease networks may offer support, and palliative care can help with symptoms and family needs at any stage of serious illness.
What should an HDL2 emergency plan include?
Keep a one-page plan with the person’s current medication list, usual behaviors and abilities, and crisis contact information. Share it with family, caregivers, and relevant clinicians, and keep it easy to find for emergencies. Review the plan whenever medicines or symptoms change.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current swallow function, do we need to schedule a FEES or videofluoroscopy to check for 'silent aspiration'?
  2. 2.What is our specific plan if I experience a psychiatric crisis, and who should I call after hours?
  3. 3.Are my current medications, like VMAT2 inhibitors, increasing my risk of falls or making me too sleepy to eat safely?
  4. 4.Can we set up a referral for a palliative care specialist to help with long-term symptom management and family support?
  5. 5.How frequently should we monitor my weight to ensure I am meeting my nutritional goals without making it burdensome?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (24)
  1. 1

    Huntington disease-like 2: insight into neurodegeneration from an African disease.

    Krause A, Anderson DG, Ferreira-Correia A, et al.

    Nature reviews. Neurology 2024; (20(1)):36-49 doi:10.1038/s41582-023-00906-y.

    PMID: 38114648
  2. 2

    Current knowledge of Huntington's disease-like 2 genetic testing, clinical presentation, and patient experiences: A systematic review.

    Hoffmann K, White S, Sexton A

    Journal of Huntington's disease 2026; (15(3)):293-316 doi:10.1177/18796397251411109.

    PMID: 41564273
  3. 3

    Clinical predictors and neural correlates for compromised swallowing safety in Huntington disease.

    Schumann-Werner B, Dogan I, Mirzazade S, et al.

    European journal of neurology 2021; (28(9)):2855-2862 doi:10.1111/ene.14953.

    PMID: 34077591
  4. 4

    Fiberoptic endoscopic evaluation of swallowing in early-to-advanced stage Huntington's disease.

    Schindler A, Pizzorni N, Sassone J, et al.

    Scientific reports 2020; (10(1)):15242 doi:10.1038/s41598-020-72250-w.

    PMID: 32943712
  5. 5

    Incidence of completed suicide and suicide attempts in a global prospective study of Huntington's disease.

    van Duijn E, Fernandes AR, Abreu D, et al.

    BJPsych open 2021; (7(5)):e158 doi:10.1192/bjo.2021.969.

    PMID: 34462049
  6. 6

    Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial.

    McGarry A, McDermott MP, Kieburtz K, et al.

    Neurology 2019; (92(14)):e1643-e1651 doi:10.1212/WNL.0000000000007244.

    PMID: 30850442
  7. 7

    Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study.

    Reilmann R, McGarry A, Grachev ID, et al.

    The Lancet. Neurology 2019; (18(2)):165-176 doi:10.1016/S1474-4422(18)30391-0.

    PMID: 30563778
  8. 8

    Comorbid epilepsy in Finnish patients with adult-onset Huntington's disease.

    Sipilä JO, Soilu-Hänninen M, Majamaa K

    BMC neurology 2016; (16()):24 doi:10.1186/s12883-016-0545-z.

    PMID: 26860086
  9. 9

    Medication Use and Treatment Indications in Huntington's Disease; Analyses from a Large Cohort.

    Feleus S, Skotnicki LEM, Roos RAC, de Bot ST

    Movement disorders clinical practice 2024; (11(12)):1530-1541 doi:10.1002/mdc3.14230.

    PMID: 39431460
  10. 10

    Dysphagia, Fear of Choking and Preventive Measures in Patients with Huntington's Disease: The Perspectives of Patients and Caregivers in Long-Term Care.

    Kalkers K, Schols JMGA, van Zwet EW, Roos RAC

    The journal of nutrition, health & aging 2022; (26(4)):332-338 doi:10.1007/s12603-022-1743-6.

    PMID: 35450988
  11. 11

    Relationship between Nutritional Status and the Severity of Huntington’s Disease. A Spanish Multicenter Dietary Intake Study.

    Cubo E, Rivadeneyra J, Armesto D, et al.

    Journal of Huntington's disease 2015; (4(1)):78-85.

    PMID: 26333259
  12. 12

    Clinical implications of malnutrition in Huntington's disease progression: evidence from a Chinese cohort and Mendelian randomization.

    Xia JQ, Cheng YF, Zhang SR, et al.

    Frontiers in nutrition 2026; (13()):1718264 doi:10.3389/fnut.2026.1718264.

    PMID: 41948286
  13. 13

    Management of dysphagia in Huntington's disease: a descriptive review.

    Pizzorni N, Pirola F, Ciammola A, Schindler A

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2020; (41(6)):1405-1417 doi:10.1007/s10072-020-04265-0.

    PMID: 31989345
  14. 14

    Effect of cognitive and motor dual-task on oropharyngeal swallowing in Parkinson's disease.

    Labeit B, Claus I, Muhle P, et al.

    European journal of neurology 2021; (28(3)):754-762 doi:10.1111/ene.14603.

    PMID: 33084118
  15. 15

    Safety and clinical impact of FEES - results of the FEES-registry.

    Dziewas R, Auf dem Brinke M, Birkmann U, et al.

    Neurological research and practice 2019; (1()):16 doi:10.1186/s42466-019-0021-5.

    PMID: 33324882
  16. 16

    Parkinsonism in Huntington's disease.

    Reilmann R

    International review of neurobiology 2019; (149()):299-306 doi:10.1016/bs.irn.2019.10.006.

    PMID: 31779817
  17. 17

    Differentiating Hyperkinetic and Hypokinetic Motor Features in the Progression of Huntington's Disease.

    Halabi N, Killoran A, Nopoulos PC, Schultz JL

    medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.04.17.25325819.

    PMID: 40313299
  18. 18

    Clinical recommendations to guide physical therapy practice for Huntington disease.

    Quinn L, Kegelmeyer D, Kloos A, et al.

    Neurology 2020; (94(5)):217-228 doi:10.1212/WNL.0000000000008887.

    PMID: 31907286
  19. 19

    An MDS Evidence-Based Review on Treatments for Huntington's Disease.

    Ferreira JJ, Rodrigues FB, Duarte GS, et al.

    Movement disorders : official journal of the Movement Disorder Society 2022; (37(1)):25-35 doi:10.1002/mds.28855.

    PMID: 34842303
  20. 20

    The burden of Huntington's disease: A prospective longitudinal study of patient/caregiver pairs.

    Youssov K, Audureau E, Vandendriessche H, et al.

    Parkinsonism & related disorders 2022; (103()):77-84 doi:10.1016/j.parkreldis.2022.08.023.

    PMID: 36084356
  21. 21

    Predictors of Caregiver Burden in Huntington's Disease.

    Hergert DC, Cimino CR

    Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists 2021; (36(8)):1426–1437 doi:10.1093/arclin/acab009.

    PMID: 33723593
  22. 22

    Huntington's disease: diagnosis and management.

    Stoker TB, Mason SL, Greenland JC, et al.

    Practical neurology 2022; (22(1)):32-41 doi:10.1136/practneurol-2021-003074.

    PMID: 34413240
  23. 23

    Palliative Care in Huntington Disease: Personal Reflections and a Review of the Literature.

    Tarolli CG, Chesire AM, Biglan KM

    Tremor and other hyperkinetic movements (New York, N.Y.) 2017; (7()):454 doi:10.7916/D88057C7.

    PMID: 28428907
  24. 24

    The Impact of Huntington Disease on Family Carers: a Literature Overview.

    Domaradzki J

    Psychiatria polska 2015; (49(5)):931-44.

    PMID: 26688844

This page provides general information about safety and daily living with HDL2 for patients and caregivers; it is for informational purposes only and does not constitute medical advice. Contact your healthcare team or local emergency services for urgent concerns.

Get notified when new evidence is published on Huntington disease-like 2.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.